Search - tctmd.com

Displaying 321 - 340 of 3160

Sort: Relevancy | Date

Presentation TCT 2023

TCT 202: Frailty Based Prediction of Major Bleeding Risk in Patients Undergoing TAVI: a POPular TAVI sub-analysis

Presenter: Dirk Jan van Ginkel

October 25, 2023

Presentation TCT 2023

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

Presenter: Eva Woelders

October 25, 2023

Presentation TCT 2023

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

Presenter: Cole Clifford

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

Presenter: Pieter Smits

October 25, 2023

News Conference News TCT 2023

Watchman, Amulet LAAO Devices Have Similar Leak Rates at About 1 Year

Todd Neale

October 25, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Presentation TCT 2023

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation

Presenter: Daniel Overduin

October 24, 2023

Presentation TCT 2023

Predicting Ischemic and Bleeding Risk in Patients after PCI on DAPT: An Individualized Patient Centered Machine Learning Model

Presenter: Roxana Mehran

October 24, 2023

Presentation TCT 2023

Routine versus selective protamine administration to reduce bleeding in transcatheter aortic valve implantation: ACE-PROTAVI

Presenter: Antony Walton

October 23, 2023

Presentation TCT 2023

Impact of High Bleeding Risk status on comparative outcomes of Physiology-guided Complete versus Culprit-Only Revascularization in older MI patients: Data from the FIRE trial

Presenter: Simone Biscaglia

October 23, 2023

News Conference News EACTS 2023

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

Michael O'Riordan

October 11, 2023

News Daily News

Complex PCI Not Without Risk in Elderly Patients With SIHD: Yale Study

Caitlin E. Cox

October 10, 2023

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

News Daily News

Similar Outcomes With Enteric-Coated and Uncoated Aspirin: ADAPTABLE

Todd Neale

October 06, 2023

News Daily News

Ultrasound Cuts Vascular Complications, Bleeds in Transfemoral Access

Yael L. Maxwell

October 05, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Daily News

Patient ‘Progressing Well’ After Second Pig-to-Human Heart Transplant

Yael L. Maxwell

September 26, 2023

News Daily News

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Michael O'Riordan

September 21, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

Advertisement

TCT 202: Frailty Based Prediction of Major Bleeding Risk in Patients Undergoing TAVI: a POPular TAVI sub-analysis

TCT 525: The Prevalence of Bleeding and Ischemic Outcomes in Patients on Triple Therapy in a Real-Practice Registry of Percutaneous Coronary Interventions

TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

Watchman, Amulet LAAO Devices Have Similar Leak Rates at About 1 Year

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation

Predicting Ischemic and Bleeding Risk in Patients after PCI on DAPT: An Individualized Patient Centered Machine Learning Model

Routine versus selective protamine administration to reduce bleeding in transcatheter aortic valve implantation: ACE-PROTAVI

Impact of High Bleeding Risk status on comparative outcomes of Physiology-guided Complete versus Culprit-Only Revascularization in older MI patients: Data from the FIRE trial

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

Complex PCI Not Without Risk in Elderly Patients With SIHD: Yale Study

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Similar Outcomes With Enteric-Coated and Uncoated Aspirin: ADAPTABLE

Ultrasound Cuts Vascular Complications, Bleeds in Transfemoral Access

TCTMD’s Top 10 Most Popular Stories for September 2023

Patient ‘Progressing Well’ After Second Pig-to-Human Heart Transplant

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content